M. Arcaro

发表

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Nick C Fox, Cory C. Funk, D. G. Clark, 2017, Nature Genetics.

MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Cells.

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer ' s disease

D. G. Clark, M. Fornage, A. Hofman, 2022 .

PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.

D. Mari, S. Sorbi, C. Mariani, 2016, Journal of Alzheimer's disease : JAD.

Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Alzheimer's disease : JAD.

Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, Brain, Behavior, and Immunity.

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation

F. Turkheimer, D. Galimberti, C. Fenoglio, 2022, Alzheimer's Research & Therapy.

miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia

D. Galimberti, C. Fenoglio, M. Serpente, 2022, International journal of molecular sciences.

Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation

D. Galimberti, C. Fenoglio, E. Scarpini, 2017, Neurology.

Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of Alzheimer's disease : JAD.

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, Biomedicines.

Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

A. Bianchi, D. Galimberti, C. Fenoglio, 2022, European Radiology.

Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect

Arosio, D. Galimberti, C. Fenoglio, 2023, GeroScience.

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2022, Nature Genetics.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

W. M. van der Flier, M. Fornage, D. Rujescu, 2021, Nature Communications.

Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, International journal of molecular sciences.

Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer’s disease and longevity in an Italian population

G. Cerroni, E. Bonanni, S. Sorbi, 2021, GeroScience.

New insights on the genetic etiology of Alzheimer’s and related dementia

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2020 .

LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients

A. Goris, D. Galimberti, C. Fenoglio, 2018, Journal of Neuroimmunology.

Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging

A. Bonfigli, C. Franceschi, D. Galimberti, 2020, GeroScience.

Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform

D. Galimberti, C. Fenoglio, E. Galliera, 2019, Immunity & Ageing.

Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

The expression pattern of GDF15 in human brain changes during aging and in Alzheimer’s disease

D. Galimberti, Valentina Fantini, S. Salvioli, 2023, Frontiers in Aging Neuroscience.

Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, Journal of Alzheimer's disease : JAD.

Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu‐Hakola Disease

D. Galimberti, C. Fenoglio, L. Piccio, 2019, Cytokine.

Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation

B. Ghetti, D. Galimberti, C. Fenoglio, 2017, Movement Disorders.

Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Journal of Alzheimer's disease : JAD.

Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, Journal of Alzheimer's disease : JAD.

Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Neuroimmunology.

Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, European journal of neurology.

variants in Alzheimer's disease and risk stratification by polygenic risk

J. Laczó, L. Brusco, B. Nordestgaard, 2023 .

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Pavel P. Kuksa, W. M. van der Flier, 2022, Nature Genetics.

Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, International journal of molecular sciences.

Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.

C. Fenoglio, R. Laforce, M. Tartaglia, 2024, Journal of Alzheimer's disease : JAD.

Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Alzheimer's Disease.

Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study

C. Fenoglio, R. Laforce, J. V. van Swieten, 2024, Brain, Behavior, and Immunity.